(TER) Teradyne - Overview
Stock: Semiconductor Testers, Collaborative Robots, Mobile Robots, Wireless Testers
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.43% |
| Yield on Cost 5y | 0.42% |
| Yield CAGR 5y | 4.66% |
| Payout Consistency | 98.1% |
| Payout Ratio | 15.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 43.8% |
| Relative Tail Risk | -10.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.46 |
| Alpha | 80.93 |
| Character TTM | |
|---|---|
| Beta | 1.858 |
| Beta Downside | 2.129 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.18% |
| CAGR/Max DD | 0.55 |
Description: TER Teradyne December 17, 2025
Teradyne (NASDAQ: TER) designs, builds, and sells automated test equipment and robotics solutions worldwide, operating through three segments: Semiconductor Test, Robotics, and Other.
The Semiconductor Test segment supplies wafer-level, package, and system-level testing platforms-including the FLEX, J750, Magnum, and ETS systems-to integrated device manufacturers, fabless designers, foundries, and test subcontractors, covering high-growth end-markets such as automotive electronics, AI-enabled chips, and 5G smartphones.
The Robotics segment offers collaborative arms, autonomous mobile robots, and advanced control software for manufacturing and logistics, while also marketing test and inspection instruments under the LitePoint brand for wireless and semiconductor validation.
Key recent metrics: FY 2023 revenue reached $3.5 billion, with the Semiconductor Test business contributing roughly 70 % of sales; operating margin held at ≈ 15 %; and the Robotics segment grew ≈ 12 % YoY, driven by rising demand for flexible automation in e-commerce fulfillment centers.
Sector drivers that materially affect Teradyne include the global semiconductor capital-expenditure cycle (average 6-7 % YoY growth in 2024), accelerating automotive electrification (projected 20 % CAGR in power-train chips), and tightening labor markets that push manufacturers toward automation.
For a deeper quantitative dive, you might explore ValueRay’s analyst toolkit.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 443.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -0.50 > 1.0 |
| NWC/Revenue: 26.41% < 20% (prev 45.44%; Δ -19.03% < -1%) |
| CFO/TA 0.17 > 3% & CFO 675.3m > Net Income 443.1m |
| Net Debt (-203.9m) to EBITDA (644.2m): -0.32 < 3 |
| Current Ratio: 1.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (159.1m) vs 12m ago -3.14% < -2% |
| Gross Margin: 58.92% > 18% (prev 0.58%; Δ 5835 % > 0.5%) |
| Asset Turnover: 73.95% > 50% (prev 72.62%; Δ 1.33% > 0%) |
| Interest Coverage Ratio: 104.5 > 6 (EBITDA TTM 644.2m / Interest Expense TTM 4.99m) |
Altman Z'' 3.35
| A: 0.19 (Total Current Assets 1.75b - Total Current Liabilities 995.0m) / Total Assets 3.96b |
| B: 0.17 (Retained Earnings 686.8m / Total Assets 3.96b) |
| C: 0.13 (EBIT TTM 521.3m / Avg Total Assets 3.87b) |
| D: 0.60 (Book Value of Equity 743.9m / Total Liabilities 1.25b) |
| Altman-Z'' Score: 3.35 = A |
Beneish M -2.87
| DSRI: 1.17 (Receivables 593.8m/484.4m, Revenue 2.86b/2.74b) |
| GMI: 0.98 (GM 58.92% / 57.76%) |
| AQI: 1.10 (AQ_t 0.40 / AQ_t-1 0.36) |
| SGI: 1.04 (Revenue 2.86b / 2.74b) |
| TATA: -0.06 (NI 443.1m - CFO 675.3m) / TA 3.96b) |
| Beneish M-Score: -2.87 (Cap -4..+1) = A |
What is the price of TER shares?
Over the past week, the price has changed by +9.92%, over one month by +27.62%, over three months by +44.91% and over the past year by +107.26%.
Is TER a buy, sell or hold?
- StrongBuy: 9
- Buy: 2
- Hold: 4
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the TER price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 211.3 | -16.1% |
| Analysts Target Price | 211.3 | -16.1% |
| ValueRay Target Price | 273.1 | 8.4% |
TER Fundamental Data Overview January 26, 2026
P/E Forward = 43.29
P/S = 12.7489
P/B = 13.2086
P/EG = 1.9347
Revenue TTM = 2.86b USD
EBIT TTM = 521.3m USD
EBITDA TTM = 644.2m USD
Long Term Debt = 68.8m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 19.0m USD (from shortTermDebt, last quarter)
Debt = 68.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -203.9m USD (from netDebt column, last quarter)
Enterprise Value = 36.23b USD (36.46b + Debt 68.8m - CCE 297.7m)
Interest Coverage Ratio = 104.5 (Ebit TTM 521.3m / Interest Expense TTM 4.99m)
EV/FCF = 79.30x (Enterprise Value 36.23b / FCF TTM 456.8m)
FCF Yield = 1.26% (FCF TTM 456.8m / Enterprise Value 36.23b)
FCF Margin = 15.98% (FCF TTM 456.8m / Revenue TTM 2.86b)
Net Margin = 15.49% (Net Income TTM 443.1m / Revenue TTM 2.86b)
Gross Margin = 58.92% ((Revenue TTM 2.86b - Cost of Revenue TTM 1.17b) / Revenue TTM)
Gross Margin QoQ = 58.41% (prev 57.23%)
Tobins Q-Ratio = 9.14 (Enterprise Value 36.23b / Total Assets 3.96b)
Interest Expense / Debt = 4.07% (Interest Expense 2.80m / Debt 68.8m)
Taxrate = 16.34% (23.3m / 142.9m)
NOPAT = 436.1m (EBIT 521.3m * (1 - 16.34%))
Current Ratio = 1.76 (Total Current Assets 1.75b / Total Current Liabilities 995.0m)
Debt / Equity = 0.03 (Debt 68.8m / totalStockholderEquity, last quarter 2.72b)
Debt / EBITDA = -0.32 (Net Debt -203.9m / EBITDA 644.2m)
Debt / FCF = -0.45 (Net Debt -203.9m / FCF TTM 456.8m)
Total Stockholder Equity = 2.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.46% (Net Income 443.1m / Total Assets 3.96b)
RoE = 15.86% (Net Income TTM 443.1m / Total Stockholder Equity 2.79b)
RoCE = 18.22% (EBIT 521.3m / Capital Employed (Equity 2.79b + L.T.Debt 68.8m))
RoIC = 15.62% (NOPAT 436.1m / Invested Capital 2.79b)
WACC = 12.74% (E(36.46b)/V(36.53b) * Re(12.76%) + D(68.8m)/V(36.53b) * Rd(4.07%) * (1-Tc(0.16)))
Discount Rate = 12.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.93%
[DCF Debug] Terminal Value 63.13% ; FCFF base≈455.4m ; Y1≈464.1m ; Y5≈510.2m
Fair Price DCF = 30.92 (EV 4.64b - Net Debt -203.9m = Equity 4.84b / Shares 156.6m; r=12.74% [WACC]; 5y FCF grow 1.70% → 2.90% )
EPS Correlation: -52.23 | EPS CAGR: -11.95% | SUE: 1.22 | # QB: 1
Revenue Correlation: -43.16 | Revenue CAGR: -3.67% | SUE: 1.86 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.22 | Chg30d=+0.015 | Revisions Net=+2 | Analysts=16
EPS next Year (2026-12-31): EPS=5.18 | Chg30d=+0.046 | Revisions Net=+1 | Growth EPS=+47.2% | Growth Revenue=+23.5%